AstraZeneca has decided to halt its £200 million investment plan at its research center in Cambridge, a project that would have created approximately 1,000 jobs. This is the company's second major withdrawal from the UK in 2024, after it abandoned a £450 million investment in vaccine manufacturing in January. The decisions of pharmaceutical companies, including Merck & Co., are putting pressure on the British government in the context of maintaining attractiveness for investments in the pharmaceutical sector.
Sources
AstraZeneca suspendă o investiţie de 270 de milioane de dolari în Marea Britanie
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
AstraZeneca pauses £200m Cambridge investment
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
Latest News
23:04
Dinamo Bucharest defeated SCM Poli Timișoara 35-25 in the first semifinal of the Romanian Supercup, marking the debut of the new season.
23:01
Rapid Bucharest defeated Petrolul Ploiești 2-0 in the first match of the sixth round of the Super League
22:53
Dominic Fritz comments on the CCR's reasoning: "We can rest easy. The sanction does not apply to me, but to my mandate."
22:45
The U.S. Supreme Court temporarily authorized the continuation of work on the White House ballroom, suspending a court order that would have halted the project.
22:24
"We have a set of measures prepared" against Russia, announces Oana Ţoiu. Romania is ready to respond diplomatically and militarily.
See more news